Phase I trial of ISIS APOCIIIRx in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Volanesorsen (Primary)
- Indications Hypertriglyceridaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
- 06 Dec 2011 Results were presented at the Cold Spring Harbor Laboratory 2(nd) RNA Therapeutics conference.
- 06 Dec 2011 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History